SCHEMBL7807313

SCHEMBL7807313

O=C(CN1CCN(Cc2ccc(Cl)cc2)CC1)Nc1ccccc1

nearest known ligand 0.90

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.90
FAAH O00519 2/20 0.71
MEN1 O00255 3/20 0.70
KMT2A Q03164 3/20 0.70
KCNA5 P22460 1/20 0.66
ALDH1A1 P00352 4/20 0.65
CACNA1G O43497 2/20 0.65
CA1 P00915 1/20 0.64
CA2 P00918 1/20 0.64
CA7 P43166 1/20 0.64
LTA4H P09960 1/20 0.63
POLB P06746 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.60
HSD17B10 Q99714 1/20 0.60
LMNA P02545 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6893687 0.85 ALDH1A1 (0.79) ATMMEN1KMT2AKCNA5ALDH1A1
SCHEMBL5749895 0.82 ATM (0.78) ATMFAAHMEN1KMT2AALDH1A1
SCHEMBL8585760 0.81 NPC1 (0.67) ATMMEN1KMT2AKCNA5ALDH1A1
SCHEMBL24489123 0.81 MEN1 (0.64) ATMMEN1KMT2AKCNA5ALDH1A1
SCHEMBL29694124 0.81 MEN1 (0.64) ATMMEN1KMT2AKCNA5ALDH1A1
SCHEMBL14192211 0.81 ALDH1A1 (0.72) ATMMEN1KMT2AKCNA5ALDH1A1
SCHEMBL6093114 0.80 FAAH (0.74) ATMFAAHCA2SMN1; SMN2
SCHEMBL8585764 0.80 REV1 (0.82) ATMFAAHMEN1KMT2AALDH1A1
SCHEMBL29057517 0.80 ALDH1A1 (0.71) ATMMEN1KMT2AALDH1A1CA1
SCHEMBL13595611 0.79 ATM (0.69) ATMMEN1KMT2AALDH1A1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1068193-A1 BENZYLPIPERAZINYL- AND BENZYLPIPERIDINYL ETHANONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D 4? RECEPTOR ANTAGONISTS NEUROGEN CORPORATION (US) 2001-01-17 EP claimed
WO-1999043670-A1 BENZYLPIPERAZINYL- AND BENZYLPIPERIDINYL ETHANONE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS DOPAMINE D4 RECEPTOR ANTAGONISTS NEUROGEN CORPORATION (US) 1999-09-02 WO claimed